AstraZeneca sells acid reflux drug rights Germany's Cheplapharm

AstraZeneca sells acid reflux drug rights to Germany's Cheplapharm

11:38 AM, 3rd October 2019
AstraZeneca logo

CAMBRIDGE, UK: AstraZeneca Plc said that it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as $276 million.

Cheplapharm will pay AstraZeneca about $243 million for Losec, a proton pump inhibitor developed by the British drugmaker. The sale also includes milestone payments of up to $33 million in 2021 and 2022 contingent on sales.

The global commercial rights being sold to Cheplapharm, for Losec (omeprazole) and its associated brands, excludes rights in China, Japan, the United States and Mexico, AstraZeneca said.

AstraZeneca said it will still make and supply Losec and its associated medicines and sell the medicine in markets where it still holds the rights.

In 2018, Losec sales in the countries covered under this agreement with Cheplapharm were $98 million, the British drugmaker said.

The divestment includes medicines containing omeprazole marketed by AstraZeneca or its collaborators sold under brands such as Acimax, Antra, Mepral, Mopral, Omepral and Zoltum.

Source: Reuters

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Archroma to present latest system solutions towards sustainable colours

REINACH, SWITZERLAND: Archroma to present its latest innovations and system solutions aimed to help technical textile manufacturers in India with opti ...

Read more
Stolt-Nielsen appoints new president for tankers business

LONDON, US: Stolt-Nielsen Limited has appointed Lucas Vos as President Stolt Tankers, with effect from 11th October 2019. Vos succeeds Mark Marte ...

Read more
Maire Tecnimont signs contract for new ammonia-urea complex with EuroChem

MILAN, ITALY: Maire Tecnimont has signed a memorandum of intent (MoI) with EuroChem, a leading global fertilizer company. According to the MoI, Tecni ...

Read more
Total completes acquiring Anadarko’s shareholding in Mozambique LNG

PARIS, FRANCE: Total SA announced the closing of the acquisition of Anadarko’s 26.5% operated interest in the Mozambique LNG project for a purch ...

Read more
AkzoNobel launches recycled paint to close the loop on waste

AMSTERDAM, NETHERLANDS: AkzoNobel NV has become the first major manufacturer to launch recycled paint in a ground-breaking partnership with UK resourc ...

Read more
EMA releases guidance on how to avoid nitrosamines in human medicines

AMSTERDAM, NETHERLANDS: European Medicines Agency’s (EMA’s) human medicines committee (CHMP) is requesting as a matter of precaution that ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X